BridgeBio Pharma Inc

NASDAQ:BBIO   3:59:57 PM EDT
11.09
-0.47 (-4.07%)
Earnings Announcements

Bridgebio Pharma Q2 Loss Per Share $0.07

Published: 08/04/2022 12:12 GMT
BridgeBio Pharma Inc (BBIO) - Bridgebio Pharma, Inc. Reports Second Quarter 2022 Financial Results and Business Update.
Bridgebio Pharma Inc - Qtrly Loss per Share $0.07.
Bridgebio Pharma Inc - Qtrly Revenue $73.75 Million Versus $54.0 Million.
Revenue is expected to be $8.63 Million
Adjusted EPS is expected to be -$0.91

Next Quarter Revenue Guidance is expected to be $9.82 Million
Next Quarter EPS Guidance is expected to be -$0.89

More details on our Analysts Page.